REFERENCES
1. Shetty PK, Baliga SV, Balaiah K. Malignant triton tumor: a rare case.Indian J Surg . 2013;75:362-5.
2. Khu KJ, Midha R. Malignant Peripheral Nerve Sheath Tumors.World neurosurg . 2016;94:566-7.
3. Bura Miljenko,Musani Vesna,Cretnik Maja et al. Hedgehog-Patched pathway aberrations in a malignant triton tumor case study. Oncol Rep .2008;20: 347-52.
4. Woodruff JM, Chernik NL, Smith MC, et al. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant ”Triton” tumors).Cancer . 1973;32:426-39.
5. Pendleton C, Everson MC, Puffer RC, et al. Personal and Familial Malignancy History in Patients with Malignant Peripheral Nerve Sheath Tumors with a Focus on Sporadic Tumors. World neurosurg .2020;141:e778-e82.
6. Bridge R S,Bridge J A,Neff J R, et al. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol .2004;57: 1172-8.
7. Seminog O O,Goldacre M J.Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer .2013;108: 193-8.
8. Mantere T, Tervasmäki A, Nurmi A, et al. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility. Sci Rep. 2017;7: 681.
9. Wang L, Wang H, Wang T, et al. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.Artif Cells Nanomed.Biotechnol. 2019;47: 1101-1112.
10. Terzic A, Bode B, Gratz KW, et al. Prognostic factors for the malignant triton tumor of the head and neck. Head Neck .2009;31:679-88.
11. Tsagozis P, Gaston CL, Haglund F, et al. The importance of surgical margins in malignant Triton tumour of the trunk and extremities.Oncol Lett .2021; 21: 120.